We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

127 hedge funds and large institutions have $784M invested in Foundation Medicine, Inc. in 2017 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 11

177% more call options, than puts

Call options by funds: $40.6M | Put options by funds: $14.7M

65% more capital invested

Capital invested by funds: $476M → $784M (+$307M)

31% more funds holding

Funds holding: 97127 (+30)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

9% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 33

Holders
127
Holders Change
+30
Holders Change %
+30.93%
% of All Funds
2.88%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
42
Increased
30
Reduced
33
Closed
11
Calls
$40.6M
Puts
$14.7M
Net Calls
+$25.9M
Net Calls Change
+$10.3M
Name Holding Trade Value Shares
Change
Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$450K
UBS Group
77
UBS Group
Switzerland
$436K -$595K -11,470 -64%
Principal Financial Group
78
Principal Financial Group
Iowa
$402K +$305K +5,891 New
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
$351K -$277K -5,347 -51%
PPA
80
Parametric Portfolio Associates
Washington
$351K +$267K +5,148 New
Teacher Retirement System of Texas
81
Teacher Retirement System of Texas
Texas
$336K +$256K +4,928 New
Two Sigma Advisers
82
Two Sigma Advisers
New York
$286K +$218K +4,200 New
II
83
Ibex Investors
Colorado
$269K +$202K +3,894 New
JP Morgan Chase
84
JP Morgan Chase
New York
$263K +$200K +3,858 New
W
85
Wealthfront
California
$259K +$197K +3,797 New
Legal & General Group
86
Legal & General Group
United Kingdom
$254K -$5.24K -101 -3%
Barclays
87
Barclays
United Kingdom
$254K +$107K +2,057 +124%
RJA
88
Raymond James & Associates
Florida
$244K +$186K +3,578 New
UBS AM
89
UBS AM
Illinois
$241K +$183K +3,535 New
FAIM
90
Financial Advocates Investment Management
Washington
$239K +$182K +3,500 New
BCM
91
BlueCrest Capital Management
Jersey
$239K +$182K +3,510 New
LCM
92
Laurion Capital Management
New York
$224K +$171K +3,288 New
CG
93
Cutler Group
California
$218K +$166K +3,200 New
Tudor Investment Corp
94
Tudor Investment Corp
Connecticut
$212K +$161K +3,109 New
BNP Paribas Financial Markets
95
BNP Paribas Financial Markets
France
$206K +$82.8K +1,596 +112%
FT
96
Fiduciary Trust
Massachusetts
$205K +$156K +3,000 New
WTC
97
WhitTier Trust Company
Nevada
$156K +$27.8K +537 +31%
Parallax Volatility Advisers
98
Parallax Volatility Advisers
California
$152K -$201K -3,880 -64%
WAM
99
Wealthspire Advisors (Maryland)
Maryland
$145K
Canada Life
100
Canada Life
Manitoba, Canada
$116K

FMI Hedge Fund Activity: Q4 2017 in Review

127 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q4 2017, worth a combined $784M — up 65% from $476M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new FMI positions and 11 closed out — a net gain of 31 holders — while 30 added to existing stakes and 33 trimmed.

The largest buyer was Hitchwood Capital Management, opening a new position worth an estimated $18.7M. The largest seller was AllianceBernstein, cutting an estimated $19.1M.

  • 127 institutional investors held Foundation Medicine, Inc. (FMI) as of Q4 2017, up from 97 in Q3 2017.
  • Funds reported $784M of Foundation Medicine, Inc. stock for Q4 2017, up 65% quarter-over-quarter.
  • 42 funds opened new Foundation Medicine, Inc. positions in Q4 2017 and 11 closed out, a net change of +31 holders.
  • The largest Foundation Medicine, Inc. buyer in Q4 2017 was Hitchwood Capital Management, an estimated $18.7M added.
  • The largest Foundation Medicine, Inc. seller in Q4 2017 was AllianceBernstein, an estimated $19.1M sold.

Based on aggregated 13F filings for Q4 2017.